5% stakes
Trails Edge Capital Partners
Institution
- 5% stake reports
- 20
- 5% stake stocks
- 14
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Faeth Therapeutics FTH08/14 | 2%515,335 sh | −7.9pp |
| Neurogene NGNE08/14 | 4.5%714,885 sh | −0.6pp |
| OnKure Therapeutics OKUR08/14 | 3.6%1,438,456 sh | −2.4pp |
| Camp4 Therapeutics CAMP08/10 | 6%3,790,636 sh | First report |
| Research Alliance Corp IV RACD07/21 | 5.5%500,000 sh | First report |
| Research Alliance Corp III RACC05/29 | 5.5%500,000 sh | First report |
| Inhibikase Therapeutics IKT05/15 | 6.1%8,057,345 sh | +1.0pp |
| ImageneBio IMA04/21 | 9.9%1,176,472 sh | First report |
| OnKure Therapeutics OKUR04/07 | 6%2,409,638 sh | First report |
| Milestone Pharmaceuticals MIST03/26 | 4.3%5,333,333 sh | −5.6pp |
| Faeth Therapeutics FTH02/25 | 9.9%126,010 sh | First report |
| Immunic IMUX02/24 | 8.7%11,454,000 sh | First report |
| X4 Pharmaceuticals XFOR02/17 | 5.8%5,227,222 sh | −4.1pp |
| ProMIS Neurosciences PMN02/10 | 9.9%933,477 sh | First report |
| Inhibikase Therapeutics IKT25/12/31 | 5.1%6,145,198 sh | First report |
| LB Pharmaceuticals LBRX25/12/31 | 5%1,268,265 sh | First report |
| Neurogene NGNE25/12/15 | 5.1%785,000 sh | First report |
| vTv Therapeutics VTVT25/09/08 | 9.9%340,536 sh | First report |
| X4 Pharmaceuticals XFOR25/08/18 | 9.9%2,317,153 sh | First report |
| Milestone Pharmaceuticals MIST25/07/21 | 9.9%8,847,882 sh | First report |
